BEIGENE(ONC) - 2025 Q3 - Quarterly Results

Exhibit 99.1 BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates SAN CARLOS, Calif. – November 6, 2025 – BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter of 2025. "These strong financial results reinforce our position as a global oncology leader with exceptional topline growth and a strong balance sheet," said John V. Oyler, Co-Founder, Chairman and CEO at Be ...